4.51 +0.04 (0.88%)
PGNX
Stock Details
Last Trade:4.51 Change:+0.04 (0.88%) Prev Close:4.47 Open: 4.52 Days Range:4.36 – 4.52 52 Week Range: 3.53 - 9.11 Volume:67092 P/E: N/AEPS:-1.45
View AllRecent Alerts 02/09/10
Recent Alert on 02/04/10 at 9:18am
Progenics Pharma (PGNX) Presents Data on Two Compounds Shown to Block Growth and Survival of Cancer Cells
Progenics Pharma (PGNX) Presents Data on Two Compounds Shown to Block Growth and Survival of Cancer Cells
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced the presentation of preclinical data on a series of novel compounds that simultaneously blocked two critical pathways involved in the growth and survival of cancer cells. The compounds... Read More
Recent Alert on 02/04/10 at 9:18am
Progenics Pharma (PGNX) Presents Data on Two Compounds Shown to Block Growth and Survival of Cancer Cells
Progenics Pharma (PGNX) Presents Data on Two Compounds Shown to Block Growth and Survival of Cancer Cells
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/10 at 11:39am
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: TUDOR INVESTMENT CORP ET AL
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: TUDOR INVESTMENT CORP ET AL
View AllRecent Blog Posts
Blog Posts on 11/20/09 at 6:07am
A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
Blog Posts on 10/14/09 at 12:09pm
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics